136 related articles for article (PubMed ID: 1156509)
1. Influence of ICRF 159 and trition WR 1339 on metastases of a rat epithelioma.
Pimm MV; Baldwin RW
Br J Cancer; 1975 Jan; 31(1):62-7. PubMed ID: 1156509
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective effects of cis- and trans-cyclopropylbis (dioxopiperazines) related to ICRF-159 on metastases of hamster lung adenocarcinoma.
Witiak DT; Lee HJ; Goldman HD; Zwilling BS
J Med Chem; 1978 Dec; 21(12):1194-7. PubMed ID: 722727
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effects of razoxane in a rat osteosarcoma model.
Wingen F; Spring H; Schmähl D
Clin Exp Metastasis; 1987; 5(1):9-16. PubMed ID: 3470164
[TBL] [Abstract][Full Text] [Related]
4. Effect of high dose diethylstilbestrol and ICRF-159 on the growth and metastases of the R3327 MAT-LyLu prostate-derived tumor.
Heston WD; Kadmon D; Fair WR
Cancer Lett; 1981 Jul; 13(2):139-45. PubMed ID: 7306951
[TBL] [Abstract][Full Text] [Related]
5. Interference with in vivo growth and metastasis of prostate adenocarcinoma (PA-III) by ICRF-159.
Pollard M; Burleson GR; Luckert PH
Prostate; 1981; 2(1):1-9. PubMed ID: 7279810
[TBL] [Abstract][Full Text] [Related]
6. The effect of (+/-) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma.
Atherton A
Eur J Cancer (1965); 1975 Jun; 11(6):383-8. PubMed ID: 1174351
[No Abstract] [Full Text] [Related]
7. Combination of radiation and razoxane (ICRF 159) in vivo.
Hellmann K; Grimshaw MB; Hutchinson GE
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):109-13. PubMed ID: 632139
[No Abstract] [Full Text] [Related]
8. Effect of AT1727 on growth and metastasis of murine tumours.
Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
[TBL] [Abstract][Full Text] [Related]
9. Effect of surgery and adjuvant chemotherapy on the R3327 MAT-Ly Lu tumor.
Kadmon D; Heston WD; Fair WR
Prostate; 1981; 2(3):299-307. PubMed ID: 7301657
[TBL] [Abstract][Full Text] [Related]
10. Prospective serial liver ultrasound scanning in resectable colorectal cancer treated with adjuvant razoxane.
Taylor RH; Gilbert JM; Evans MG; Lane HG; Cassell PG
Clin Exp Metastasis; 1984; 2(4):321-31. PubMed ID: 6399698
[TBL] [Abstract][Full Text] [Related]
11. Studies in mice treated with ICRF-159 combined with daunorubicin or doxorubicin.
Giuliani F; Casazza AM; Di Marco A; Savi G
Cancer Treat Rep; 1981; 65(3-4):267-76. PubMed ID: 6263470
[TBL] [Abstract][Full Text] [Related]
12. Retention of 241Am and 239Pu in the rat as influenced by triton WR 1339.
Gruner R; Seidel A
Health Phys; 1976 Aug; 31(2):182-4. PubMed ID: 972063
[No Abstract] [Full Text] [Related]
13. The influence of ICRF-159 and levamisole on the incidence of metastases following local irradiation of a solid tumor.
Baker D; Constable W; Elkon D; Rinehart L
Cancer; 1981 Nov; 48(10):2179-83. PubMed ID: 7296476
[TBL] [Abstract][Full Text] [Related]
14. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
Bakowski MT
Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
[No Abstract] [Full Text] [Related]
15. Effects of DTIC, DM-COOK and ICRF-159 on the number of circulating Lewis lung carcinoma cells detected by flow cytometry.
Giraldi T; Sava G; Cherubino R; Bottiroli G; Mazzini G
Clin Exp Metastasis; 1984; 2(2):151-9. PubMed ID: 6543695
[TBL] [Abstract][Full Text] [Related]
16. Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma.
Zwilling BS; Campolito LB; Reiches NA; George T; Witiak DT
Br J Cancer; 1981 Oct; 44(4):578-83. PubMed ID: 7295515
[TBL] [Abstract][Full Text] [Related]
17. ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues.
Kovacs CJ; Evans MJ; Burholt DR; Schenken LL
Br J Cancer; 1979 May; 39(5):524-30. PubMed ID: 486308
[TBL] [Abstract][Full Text] [Related]
18. Levamisole treatment of local and metastatic growth of transplanted rat tumours.
Hopper DG; Pimm MV; Baldwin RW
Br J Cancer; 1975 Sep; 32(3):345-51. PubMed ID: 1233079
[TBL] [Abstract][Full Text] [Related]
19. A clinical evaluation of ICRF 159 as a radiosensitising agent.
Bates T
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):127-31. PubMed ID: 344288
[No Abstract] [Full Text] [Related]
20. ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response.
Kovacs CJ; Evans MJ; Schenken LL; Burholt DR
Br J Cancer; 1979 May; 39(5):516-23. PubMed ID: 486307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
